跳至主要内容
临床试验/ACTRN12620000433909
ACTRN12620000433909已完成2 期

Effect of eye drops on accommodative response and pupil size in healthy volunteers

Brien Holden Vision Institute0 个研究点目标入组 30 人开始时间: 2020年4月1日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 35 Years(—)
性别
All

入选标准

  • (i) Able to read and comprehend English and give informed consent as demonstrated by signing a record of informed consent.
  • (ii) Be between 18 to 35 years old, male or female.
  • (iii) Willing to comply with instillation of eye drops and clinical trial visit schedule as directed by the Investigator.
  • (iv) Have ocular health findings considered to be normal”.

排除标准

  • (i) Any pre-existing ocular irritation, injury or condition (including infection or disease).
  • (ii)Any systemic disease that adversely affects ocular health e.g. diabetes, Graves disease, and autoimmune diseases such as ankylosing spondylitis, multiple sclerosis, Sjögrens syndrome and systemic lupus erythematosus. Conditions such as systemic hypertension and arthritis do not automatically exclude prospective participants.
  • (iii) Use of or a need for concurrent category S3 and above ocular medication at enrolment and/or during the clinical trial.
  • (iv) Use of or a need for any systemic medication or topical medications which may alter normal ocular findings / are known to affect a participant’s ocular health / physiology or contact lens performance either in an adverse or beneficial manner at enrolment and/or during the clinical trial.
  • NB: Systemic antihistamines are allowed on an as needed basis”, provided they are not used prophylactically during the trial and at least 24 hours before the clinical trial product is used.
  • (v) Eye surgery within 12 weeks immediately prior to enrolment for this trial.
  • (vi) Previous corneal refractive surgery.
  • (vii) Known allergy or intolerance to ingredients in any of the clinical trial products (atropine and caffeine).
  • (viii) Currently enrolled in another clinical trial.
  • (ix) Participation in a clinical trial within the previous 2 weeks for dispensing studies and 48 hours between in-house studies.
  • (x) Pregnancy and breastfeeding*.
  • The Investigator may, at his/her discretion, exclude anyone who they believe may not be able to fulfil the clinical trial requirements or it is believed to be in the participant’s best interests.
  • *Formal testing of pregnancy is not required. A participant’s verbal report is sufficient.

研究者

发起方
Brien Holden Vision Institute

相似试验

Evaluation of effect of eye drops on healthy... | 临床试验